Listed at Nasdaq Copenhague Exchange (Stock Symbol: GMAB)
How to Open a Trading Account to Invest in Genmab Shares
Opening an investment account with a stockbroker requires you to:
First, choose the broker that best fits you. Here, we present eToro as the primary choice.
Upload an ID and a proof of address (electricity, water bills, etc.) through the Broker's App or via email.
Whether you open it with eToro or with another broker, make sure to choose the correct base currency of the account. With some brokers, changing it once you open the account can be painful. Trading Accounts are available in US Dollars (USD), Euros (EUR), Pound Sterling (GBP), Swiss Franc (CHF), Australian Dollar (AUD) as the base currency. Practically all of them offer the option in US Dollars or Euros.
Once the Broker has approved the account, it's time to deposit cash. The depositing and withdrawing money methods are usually Credit Cards, Bank Transfers or eWallets (PayPal, PaySafe, Skrill, SafetyPay, Neteller, among others). The available options to deposit funds will depend on each Broker. A vital fact to mention is that all of the Brokers presented above allow you to use a simulator on their platform; that is, they allow testing their Demo account, which is Free. In other words, you can open a Demo account, try the platform, and then decide whether to deposit money or not.
Upon the capital is credited into your credited account, you may now buy the Stock.
Is it easy to invest in Genmab Shares?
Online Brokers allow investing in Shares straightforwardly through optimized apps that grant easy and fast access to financial markets. In fact, most platforms resemble a social network or any other phone app: They are designed so that the investor can learn and start trading very quickly, without the need for much prior knowledge. Literally, to buy shares of Genmab, you have to:
open a trading account as explained before,
deposit money,
Search for "Genmab" on the Broker's Trading platform, and
press the "Buy" button.
And, done, you are officially investing in the co's shares.
How to buy Genmab Shares
About Genmab
Genmab A/S was founded in 1999 and is based in Copenhagen, Denmark. It is a global biotechnology company specialising in the creation and development of differentiated antibody therapeutics for the treatment of cancer. The company has two approved antibodies, DARZALEX® for the treatment of multiple myeloma indications, and Arzerra® for the treatment of chronic lymphocytic leukaemia indications. Genmab also has a clinical and pre-clinical product pipeline.
